Teva Takeda to Copromote Allermist AG with Ceolia

Teva Takeda Pharma said on March 27 that it has formed a copromotion partnership with Ceolia Pharma …

Teva Takeda Prepping for Listing of Allermist AG in June

Azilva, Allermist Authorized Generics to Hit Japan Market on June 16. June 16, 2023 · Teva Takeda to Copromote Allermist AG with Ceolia. March 28 ...

Conclusion of Basic Agreement on Transfer of Assets and ...

Takeda and Teva Takeda announced that they have entered into a basic agreement regarding the transfer of assets and manufacturing and ...

Takeda Enters Collaboration and Licensing Agreement with Zedira ...

Falk Pharma GmbH today announced a collaboration and licensing agreement to develop ZED1227/TAK-227, a Phase 2b investigational therapy for the ...

Takeda Acquires PvP Biologics Following Results of a Phase 1 ...

Osaka, Japan, February 26, 2020–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) announced that it has acquired PvP ...

Takeda Acquires License for First-In-Class Celiac Disease Therapy ...

(“COUR”) today announced that Takeda has acquired an exclusive global license to develop and commercialize the investigational medicine CNP-101/ ...

Takeda and Cour Partner to Develop Novel Therapies for Celiac ...

today announced a partnership to research and develop novel immune modulating therapies for the potential treatment of celiac disease. The partnership will ...

The true burden of celiac disease: Bill's journey | Takeda Stories

Celiac disease means gluten harms the small intestine. A gluten-free diet is the only way to manage the disease. Bill says the diet is not ...

TAK-062-2001 | Clinical Trial Summary

Clinical Trial search tool for Takeda sponsored clinical trials and provide easy searchability for information on a particular condition/disease; ...